FS222

· InvoX Pharma Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FS222, covering 2025-07-01 to 2025-07-01. Get the full timeline:

Most recent: Clinical Trial Update: FS222 First in Human Study in Patients With Advanced Malignancies [Phase 1]